Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 4 | 1 |
| List of Figures | 4 | 1 |
| Introduction | 5 | 1 |
| Global Markets Direct Report Coverage | 5 | 1 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Overview | 6 | 1 |
| Therapeutics Development | 7 | 3 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Products under Development by Stage of Development | 7 | 1 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Products under Development by Therapy Area | 8 | 1 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Products under Development by Indication | 9 | 1 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Pipeline Products Glance | 10 | 1 |
| Early Stage Products | 10 | 1 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Products under Development by Companies | 11 | 2 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Products under Development by Universities/Institutes | 13 | 2 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Therapeutics Assessment | 15 | 4 |
| Assessment by Monotherapy/Combination Products | 15 | 1 |
| Assessment by Mechanism of Action | 16 | 1 |
| Assessment by Route of Administration | 17 | 1 |
| Assessment by Molecule Type | 18 | 1 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Companies Involved in Therapeutics Development | 19 | 6 |
| Amgen Inc. | 19 | 1 |
| Genentech, Inc. | 20 | 1 |
| Jeil Pharmaceutical Co., Ltd. | 21 | 1 |
| Kyowa Hakko Kirin Co., Ltd. | 22 | 1 |
| Novartis AG | 23 | 1 |
| Sprint Bioscience AB | 24 | 1 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Drug Profiles | 25 | 9 |
| G-007LK Drug Profile | 25 | 1 |
| G-244LM Drug Profile | 26 | 1 |
| JPI-547 Drug Profile | 27 | 1 |
| K-756 Drug Profile | 28 | 1 |
| NVPTNKS-656 Drug Profile | 29 | 1 |
| Small Molecules to Inhibit Tankyrase for Colorectal Cancer and Breast Cancer Drug Profile | 30 | 1 |
| Small Molecules to Inhibit Tankyrase for Oncology Drug Profile | 31 | 1 |
| Small Molecules to Inhibit Tankyrase for Oncology and Degenerative Disorders Drug Profile | 32 | 1 |
| Small Molecules to Inhibit Tankyrases for Oncology Drug Profile | 33 | 1 |
| Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) Dormant Projects | 34 | 1 |
| Appendix | 35 | 2 |
| Methodology | 35 | 1 |
| Coverage | 35 | 1 |
| Secondary Research | 35 | 1 |
| Primary Research | 35 | 1 |
| Expert Panel Validation | 35 | 1 |
| Contact Us | 35 | 1 |
| Disclaimer | 36 | 1 |